Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/52335
Campo DC Valoridioma
dc.contributor.authorMealiffe, Matthew E.en_US
dc.contributor.authorDe La Hoya, Miguelen_US
dc.contributor.authorFernández, Juan M.en_US
dc.contributor.authorTosar, Aliciaen_US
dc.contributor.authorGodino, Javieren_US
dc.contributor.authorSánchez De Abajo, Anaen_US
dc.contributor.authorVidart, José A.en_US
dc.contributor.authorPérez-Segura, Pedroen_US
dc.contributor.authorDíaz-Rubio, Eduardoen_US
dc.contributor.authorCaldés, Trinidaden_US
dc.date.accessioned2018-11-25T19:26:39Z-
dc.date.available2018-11-25T19:26:39Z-
dc.date.issued2003en_US
dc.identifier.issn0098-7484en_US
dc.identifier.urihttp://hdl.handle.net/10553/52335-
dc.description.abstractTo the Editor: Dr de la Hoya and colleagues found that in families with breast and/or ovarian cancer, mutations in BRCA1 but not BRCA2 were associated with a sex ratio skewed against male births. However, because the authors did not assess for several possible sources of confounding, their results may not permit the conclusion that BRCA1 mutations are associated with an asymmetrical sex ratio. The highly penetrant breast and ovarian cancer in BRCA1 families is an example of an autosomal dominant sex-limited phenotype. That is, only females carrying a BRCA1 mutation can develop ovarian cancer, and the majority of cases of breast cancer in families with the BRCA1 mutation also occurs in females.en_US
dc.languageengen_US
dc.relation.ispartofJAMA - Journal of the American Medical Associationen_US
dc.sourceJournal of the American Medical Association[ISSN 0098-7484],v. 290, p. 2544-2545en_US
dc.subject32 Ciencias médicasen_US
dc.subject320713 Oncologíaen_US
dc.titleSex Ratios in Families with BRCA Mutations [4] (multiple letters)en_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1001/jama.290.19.2544-aen_US
dc.identifier.scopus0345714920-
dc.contributor.authorscopusid57202730382-
dc.contributor.authorscopusid57204609178-
dc.contributor.authorscopusid55455043900-
dc.contributor.authorscopusid36840103700-
dc.contributor.authorscopusid57204082039-
dc.contributor.authorscopusid8503270400-
dc.contributor.authorscopusid6603705765-
dc.contributor.authorscopusid6603077606-
dc.contributor.authorscopusid6701333643-
dc.contributor.authorscopusid7004899792-
dc.description.lastpage2545en_US
dc.description.firstpage2544en_US
dc.relation.volume290en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages2en_US
dc.utils.revisionen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameSanchez De Abajo,Ana-
Colección:Comentario
Vista resumida

Citas SCOPUSTM   

2
actualizado el 13-oct-2024

Visitas

82
actualizado el 07-sep-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.